Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationCommittee for Medicinal Products for Human Use (CHMP) 19-22 February 2024
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 February 2024
Countries that have decreased their consumption of antibiotics in both animals and humans have seen a reduction in antibiotic-resistant bacteria.
View the streams from last week's FDA, MHRA, Health Canada Symposium
Available now on the ICH website The ICH E2D(R1) draft Guideline on “Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports (ICSRs)” reached Step 2b of the ICH Process in February 2024 and entered the consultation period.
Dame June Raine, MHRA's Chief Executive, will be stepping down in the Autumn following five years in the role
Process changes from 1 March 2024 build on measures already implemented by the agency
EMA consultations open for comment now.
GMP for API
Draft guidance, Released January 2024.